CN Patent

CN112153966A — 肾上腺素喷雾制剂

Assigned to Bryan Pharmaceutical Co ltd · Expires 2020-12-29 · 5y expired

What this patent protects

本文提供了肾上腺素喷雾制剂。本文还提供了通过向需要这种治疗的受试者施用肾上腺素喷雾制剂来治疗过敏反应的方法。

USPTO Abstract

本文提供了肾上腺素喷雾制剂。本文还提供了通过向需要这种治疗的受试者施用肾上腺素喷雾制剂来治疗过敏反应的方法。

Drugs covered by this patent

cetirizine-hydrochloride (CETIRIZINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN112153966A
Jurisdiction: CN
Classification: —
Expires: 2020-12-29
Drug substance claim: No
Drug product claim: No
Assignee: Bryan Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.